Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > SNN Network Canada Virtual Event on December 7-9, 2021

<< Previous

Bullboard Posts

Next >>

Comment by Domino55on Dec 06, 2021 6:48pm

129 Views

Post# 34204181

RE:RE:RE:RE:RE:RE:SNN Network Canada Virtual Event on December 7-9, 2021

Bay Street:since you have found Jesus and are an apologist now I'll remind you that the SP is down 60% since the CEO took over. Even at that previous level it was valued at 5% of NPV. On your conversion date it stands at 2% NPV and 10% of their lone analyst target price. That is using Spectral's own projections. This is as the P3 trial advances to near assured approval.

I can see how this reality has driven you to convert to a company man.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management